A. Shah

发表

The estimation of the plasma free fraction of cyclosporine in rabbits and heart transplant patients: The application of a physiological model of renal clearance

K. Lake, R. Brundage, A. Shah, 1995, Biopharmaceutics & drug disposition.

Are routine sensitivity test data suitable for the surveillance of resistance? Resistance rates amongst Escherichia coli from blood and CSF from 1991-1997, as assessed by routine and centralized testing.

D. Livermore, D. James, A. Johnson, 2000, The Journal of antimicrobial chemotherapy.

Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose.

Jerome J. Schentag, J. Wilton, D. Nix, 1999, The Journal of antimicrobial chemotherapy.

Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.

A. Shah, A. Flessas, J. Singh, 1984, The American journal of cardiology.

A Comparative Clinical Trial of Rose Petal (Gul Gulaab), Rose Hydrosol Diluted (Arq Gulaab), and Rose Hydrosol (Ruh Gulaab) in Insomnia.

S. Urooj, A. Shah, A. Habib, 2008 .

Radio Receptor Assay of Serum Neuroleptic Levels in Psychiatric Patients

J. Krska, S. Soni, A. Shah, 1986, British Journal of Psychiatry.

Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects

J. Lettieri, J. Wilton, D. Nix, 1995, Antimicrobial agents and chemotherapy.

Altered Pharmacokinetics of Indinavir by a Novel Nonnucleoside Reverse Transcriptase Inhibitor (HBY‐097): A Pharmacokinetic Evaluation in HIV‐Positive Patients

S. Hayashi, F. Aweeka, A. Shah, 1999, Journal of clinical pharmacology.

Pharmacokinetic model for subcutaneous absorption of cyclosporine in the rabbit during chronic treatment.

A. Gratwohl, R. Brundage, A. Shah, 1992, Journal of pharmaceutical sciences.

Urinary excretion of citrate in humans following administration of acetazolamide (diamox).

B. Becker, A. Shah, M. Constant, 1958, A.M.A. archives of ophthalmology.

Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension.

M. C. Liu, A. Shah, D. Vaughan, 1999, The Journal of antimicrobial chemotherapy.

Improved liquid-chromatographic determination of cyclosporine and its metabolites in blood.

A. Shah, R. Sawchuk, 1988, Clinical chemistry.

A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly.

E. Eisenhauer, R. Donehower, A. Macleod, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

COMPARISON OF EFFICACY OF ROPIVACINE ALONE WITH TRAMADOL - ROPIVACAINE COMBINATION IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR UPPER LIMB SURGERY

N. Akhtar, A. Shah, Zarqa, 2015 .

Comparative pharmacokinetics and safety of ciprofloxacin 400 mg i.v. thrice daily versus 750 mg po twice daily.

R. Echols, J. Lettieri, A. Shah, 1994, The Journal of antimicrobial chemotherapy.

Neuroleptic discontinuation in the very stable schizophrenic patient: Relapse rates and serum neuroleptic levels

A. Shah, S. D. Soni, J. Krska, 1992 .

Phase I population pharmacokinetics of irofulven

E. Raymond, E. Brain, E. Cvitkovic, 2003, Anti-cancer drugs.

Enteric absorption of ciprofloxacin during the immediate postoperative period.

L. Degutis, S. Cohn, A. Shah, 1995, The Journal of antimicrobial chemotherapy.

A double-blind, placebo-controlled trial of sustained-release diltiazem in patients with angina. Sustained-Release Diltiazem Study Group.

N. Bittar, R. Weiss, A. Shah, 1993, Clinical Therapeutics.

Plasma‐Level Response Relationships with Fluoxetine and Zimelidine

N. Fineberg, D. Baldwin, S. Montgomery, 1990, Clinical neuropharmacology.

Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.

J. Lettieri, A. Shah, D. Sica, 1996, The Journal of antimicrobial chemotherapy.

Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation

A. Shah, S. D. Soni, J. Krska, 1992, Acta psychiatrica Scandinavica.

Pharmacokinetics of oral and intravenous dolasetron mesylate in patients with renal impairment.

C. Halstenson, A. Shah, S. Weir, 1998, Journal of clinical pharmacology.

Effect of Age and Gender on the Safety, Tolerability, and Pharmacokinetics of BAY 12–9566 in Healthy Subjects

C. Lathia, P. Sundaresan, A. Shah, 2001, Journal of clinical pharmacology.

A1001 INTRATHECAL NARCOTICS FOR LABOREFFICACY OF MORPHINE 0.5mg, 0.75mg, 1.0mg, COMBINED WITH FENTANYL 25 MICROGRAMS

A. Shah, A. Mankad, D. DARK-MEZICK, 1990 .

Effects of single oral dose administration of a hydantoin prostaglandin analogue BW 245C in man.

A. Webster, J. O'grady, A. Shah, 1984, Life sciences.